Comment on “A pilot trial of G3139, a bcl-2 antisense oligonucleotide, and paclitaxel in patients with chemorefractory small-cell lung cancer”, by C. M. Rudin et al. (Ann Oncol 2002; 13: 539–545)
Options
BORIS DOI
Publisher DOI
Date of Publication
2003
Publication Type
Article
Subject(s)
Language(s)
en
Contributor(s)
Zangemeister-Wittke, U. | |
Stahel, R. A. |
Additional Credits
Series
Annals of oncology
Publisher
Oxford University Press
ISSN
0923-7534
Access(Rights)
open.access